A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S. Lightcap, Dennis Huszar, Keli Song et al.|Science Translational Medicine|2021Cited by 139
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancerSushil Kumar, Rumela Chakrabarti, Ratnesh Kumar Srivastav et al.|Oncogene|2018Cited by 96
Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast CellsAlexandr Plotnikov, Serge Y. Fuchs|Cancer Research|2009Cited by 51
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancerZhen Lu, Serge Y. Fuchs|Nature Communications|2022Cited by 33
Regulation of intercellular biomolecule transfer–driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Serge Y. Fuchs|Journal of Clinical Investigation|2021Cited by 20